Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 12:36 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | ISZO CAPITAL LP | 1,925,311 6.5% | 1,925,311 (New Position) | View |
| 2022-02-11 3:36 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | Cove Street Capital LLC | 1,796,364 6.09% | 187,746 (+11.67%) | View |
| 2022-02-10 08:22 am Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | VANGUARD GROUP INC | 1,257,836 4.27% | -414,005 (-24.76%) | View |
| 2022-02-08 3:52 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | DIMENSIONAL FUND ADVISORS LP | 1,973,608 6.7% | -245,753 (-11.07%) | View |
| 2022-02-01 5:08 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | BlackRock Inc. BLK | 1,946,458 6.6% | -144,572 (-6.91%) | View |
| 2022-01-20 4:16 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,577,705 12.1% | 387,400 (+12.14%) | View |
| 2021-08-30 5:07 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 2,928,090 9.94% | 23,750 (+0.82%) | View |
| 2021-04-20 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,190,305 10.9% | 507,905 (+18.93%) | View |
| 2021-03-25 4:27 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | Cove Street Capital LLC | 1,608,618 5.49% | 1,608,618 (New Position) | View |
| 2021-02-12 5:13 pm Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | DIMENSIONAL FUND ADVISORS LP | 2,219,361 7.6% | -212,172 (-8.73%) | View |
| 2021-02-10 11:14 am Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | VANGUARD GROUP INC | 1,671,841 5.72% | 52,739 (+3.26%) | View |
| 2021-01-29 5:23 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | BlackRock Inc. BLK | 2,091,030 7.2% | 79,319 (+3.94%) | View |
| 2020-08-24 09:15 am Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 2,904,340 9.93% | 38,000 (+1.33%) | View |
| 2020-07-10 06:19 am Sale | 13G | LIFECORE BIOMEDICAL INC. LFCR | NWQ INVESTMENT MANAGEMENT COMPANY LLC | 893,126 3.061% | -1,215,468 (-57.64%) | View |
| 2020-06-22 4:43 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 2,866,340 9.82% | 484,847 (+20.36%) | View |
| 2020-03-30 4:27 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 2,381,493 8.17% | 298,842 (+14.35%) | View |
| 2020-03-03 4:29 pm Purchase | 13D | LIFECORE BIOMEDICAL INC. LFCR | Legion Partners Asset Management LLC | 2,082,651 7.14% | 581,106 (+38.70%) | View |
| 2020-02-12 12:51 pm Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | Russell Investments Group Ltd. | 2,591,554 8.9% | 2,591,554 (New Position) | View |
| 2020-02-12 11:25 am Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | DIMENSIONAL FUND ADVISORS LP | 2,431,533 8.34% | 99,877 (+4.28%) | View |
| 2020-02-12 11:16 am Purchase | 13G | LIFECORE BIOMEDICAL INC. LFCR | VANGUARD GROUP INC | 1,619,102 5.55% | 15,181 (+0.95%) | View |